What does DR. MARC SMETS do?

DR. MARC SMETS is a general practice in Mol. Private Limited, started on 5 April 2000, 1 establishment.

What is the address of DR. MARC SMETS?

The registered office of DR. MARC SMETS is located at Rozenberg 149, 2400 Mol.

Is DR. MARC SMETS still active?

Yes. According to the CBE (28 September 2026) DR. MARC SMETS is active, legal situation “Normale toestand”, started on 5 April 2000.

Is DR. MARC SMETS registered on Peppol?

Yes, DR. MARC SMETS is registered on the Peppol network with ID 0208:0471665567.

What is the enterprise number of DR. MARC SMETS?

The enterprise number of DR. MARC SMETS is BE0471665567.

When was DR. MARC SMETS founded?

DR. MARC SMETS was founded on 5 April 2000.

Who are the directors of DR. MARC SMETS?

According to the 2025 annual accounts, the directors of DR. MARC SMETS are: Marc Jozef Smets.

Is DR. MARC SMETS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 April 2000; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. MARC SMETS make in 2025?

DR. MARC SMETS posted a profit after taxes of € 227,962 in financial year 2025.

What is the revenue of DR. MARC SMETS?

As a small company, DR. MARC SMETS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 469,113.

DR. MARC SMETS (Private Limited) - Mol - BE0471665567

Dossier DR. MARC SMETS, printed on 28 September 2026 from databakkes.be/en/0471665567/dr-marc-smets. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 47 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

DR. MARC SMETS from Mol, company number BE0471665567, closed financial year 2025 with a result of € 227,962 after tax. For that financial year DR. MARC SMETS recorded a gross margin of € 469,113 and equity of € 1.3 million. Compared with financial year 2024, the result moved from € 274,001 to € 227,962. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.

What it is worth Growing

€ 1.3 million

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 227,962

▼ 17% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 336,792

▲ 119% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 127,390 paid out

56 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Wage cost

€ 12,832

▼ 3% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 103,662

▲ 291% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 88,074

€ 24,339 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 3,102

▼ 40% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 21,696

▼ 38% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 312,168 Gross margin 2022: € 312,168 First fiscal year in the series	€ 347,715 Gross margin 2023: € 347,715 ▲ 11% vs 2022 (€ 312,168) Favourable step	€ 401,564 Gross margin 2024: € 401,564 ▲ 15% vs 2023 (€ 347,715) Favourable step	€ 469,113 Gross margin 2025: € 469,113 ▲ 17% vs 2024 (€ 401,564) Favourable step	▲ 17%
Profit after taxes	€ 167,483 Profit after taxes 2022: € 167,483 First fiscal year in the series	€ 265,984 Profit after taxes 2023: € 265,984 ▲ 59% vs 2022 (€ 167,483) Favourable step	€ 274,001 Profit after taxes 2024: € 274,001 ▲ 3% vs 2023 (€ 265,984) Favourable step	€ 227,962 Profit after taxes 2025: € 227,962 ▼ 17% vs 2024 (€ 274,001) Unfavourable step	▼ 17%
Equity	€ 2,316,112 Equity 2022: € 2,316,112 First fiscal year in the series	€ 2,582,096 Equity 2023: € 2,582,096 ▲ 11% vs 2022 (€ 2,316,112) Favourable step	€ 1,243,978 Equity 2024: € 1,243,978 ▼ 52% vs 2023 (€ 2,582,096) Unfavourable step	€ 1,344,550 Equity 2025: € 1,344,550 ▲ 8% vs 2024 (€ 1,243,978) Favourable step	▲ 8%
Total debts	€ 125,634 Total debts 2022: € 125,634 First fiscal year in the series	€ 106,422 Total debts 2023: € 106,422 ▼ 15% vs 2022 (€ 125,634) Favourable step	€ 836,378 Total debts 2024: € 836,378 ▲ € 729,956 vs 2023 (€ 106,422) Unfavourable step	€ 862,792 Total debts 2025: € 862,792 ▲ 3% vs 2024 (€ 836,378) Unfavourable step	▲ 3%
Cash	€ 696,401 Cash 2022: € 696,401 First fiscal year in the series	€ 405,078 Cash 2023: € 405,078 ▼ 42% vs 2022 (€ 696,401) Unfavourable step	€ 153,490 Cash 2024: € 153,490 ▼ 62% vs 2023 (€ 405,078) Unfavourable step	€ 336,792 Cash 2025: € 336,792 ▲ 119% vs 2024 (€ 153,490) Favourable step	▲ 119%
Land & buildings	€ 975,454 Land & buildings 2022: € 975,454 First fiscal year in the series	€ 932,720 Land & buildings 2023: € 932,720 ▼ 4% vs 2022 (€ 975,454) Unchanged	€ 889,986 Land & buildings 2024: € 889,986 ▼ 5% vs 2023 (€ 932,720) Unchanged	€ 743,350 Land & buildings 2025: € 743,350 ▼ 16% vs 2024 (€ 889,986) Unchanged	▼ 16%
Retained profit	€ 1,397,512 Retained profit 2022: € 1,397,512 First fiscal year in the series	€ 1,663,496 Retained profit 2023: € 1,663,496 ▲ 19% vs 2022 (€ 1,397,512) Favourable step	€ 1,243,978 Retained profit 2024: € 1,243,978 ▼ 25% vs 2023 (€ 1,663,496) Unfavourable step	€ 1,344,550 Retained profit 2025: € 1,344,550 ▲ 8% vs 2024 (€ 1,243,978) Favourable step	▲ 8%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 693,518 Dividend 2024: € 693,518 Unchanged (€ 0) Unchanged	€ 127,390 Dividend 2025: € 127,390 ▼ 82% vs 2024 (€ 693,518) Unchanged	▼ 82%
Bank debt	€ 30,483 Bank debt 2022: € 30,483 First fiscal year in the series	€ 13,116 Bank debt 2023: € 13,116 ▼ 57% vs 2022 (€ 30,483) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 13,116) Favourable step	€ 88,074 Bank debt 2025: € 88,074 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 2,441,746 Balance sheet total 2022: € 2,441,746 First fiscal year in the series	€ 2,688,517 Balance sheet total 2023: € 2,688,517 ▲ 10% vs 2022 (€ 2,441,746) Unchanged	€ 2,080,357 Balance sheet total 2024: € 2,080,357 ▼ 23% vs 2023 (€ 2,688,517) Unchanged	€ 2,207,342 Balance sheet total 2025: € 2,207,342 ▲ 6% vs 2024 (€ 2,080,357) Unchanged	▲ 6%

Key figures of DR. MARC SMETS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. MARC SMETS?

What happened at DR. MARC SMETS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 10, 2026 New annual accounts for financial year 2025: profit of € 227,962 (▼ 17% vs 2024). Source: NBB ↗
Apr 5, 2000 New establishment in Mol. KBO
2000 Marc Jozef Smets became a director. NBB
Apr 5, 2000 Start of the company according to the CBE. KBO

In short

From € 167,483 profit in 2022 to € 227,962 profit in 2025.

Paid € 386,906 in corporate taxes since 2022.

Best year ever: 2024, with € 274,001 profit.

Paid out € 820,908 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. MARC SMETS? We notify you, reason included.

Follow DR. MARC SMETS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Marc Jozef Smets

DR. MARC SMETS

Behind DR. MARC SMETS is Marc Jozef Smets.

See the full network in the app

Directors

According to the 2025 annual accounts

Marc Jozef Smets

Director

since 2000

Establishments

Establishment units

Physical locations of this company

Registered office

Rozenberg 149

2400 Mol

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0471.665.567
VAT number: BE 0471.665.567
Registered office: Rozenberg 149, 2400 Mol
Names & denominations: DR. MARC SMETS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 5 April 2000
Peppol: Active · Active since 22 Dec 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗